Bangladesh's transition out of the Least Developed Countries (LDC) bracket to a developing nation will bring several ...

BANGLADESH’S pharmaceutical sector has experienced remarkable growth over the past few decades, transforming from a largely ...

As a least developed country, Bangladesh's pharmaceutical industry has flourished by producing medicines with patent benefits under a WTO agreement, while the agro-chemical sector has struggled to ...

Experts at a panel discussion during the Bangladesh Investment Summit 2025 on Thursday encouraged investors to capitalise on ...

Highlights: Bangladesh produces only 41 of 400 needed APIs, relying on imports for 80% Pharma market is worth $2.92b, projected to hit $6.17b in five years Local firms meet 98% of medicine demand, but ...

Bangladesh, one of South Asia’s fastest-growing economies, holds immense potential in the healthcare sector. However, the country’s health system currently faces several critical challenges — ...

Bangladesh’s imminent graduation from Least Developed Country (LDC) status marks a significant milestone in its economic ...

South Korean investors are set to make significant investments in Bangladesh following the interim government`s efforts to ...